Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,711,345
-
Total 13F shares
-
34,945,208
-
Share change
-
+387,535
-
Total reported value
-
$824,516,432
-
Price per share
-
$23.83
-
Number of holders
-
69
-
Value change
-
+$9,797,076
-
Number of buys
-
26
-
Number of sells
-
29
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q2 2020
As of 30 Jun 2020 Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,945,208 shares of stock of the company.
Largest 10 holders included Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, Redmile Group, LLC, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., and FMR LLC.
This table shows 69 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.